Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2589 R.b.
2. Abactal
3. Dihydrate, Pefloxacin Mesylate
4. Mesylate Dihydrate, Pefloxacin
5. Mesylate, Pefloxacin
6. Peflacine
7. Pefloxacin
8. Pefloxacin Mesylate
9. Pefloxacin, Silver
10. Pefloxacine
11. R.b., 2589
12. Silver Pefloxacin
1. 149676-40-4
2. Peflacine
3. Peflox
4. Pefloxacin (mesylate Dihydrate)
5. 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic Acid
6. Cx28qc6fu0
7. Pefloxacin Mesilate Dihydrate
8. Pefloxacin Mesylate Dihydrate
9. Pefloxacinium Mesylate Dihydrate
10. 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic Acid;methanesulfonic Acid;dihydrate
11. 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Methanesulfonate Dihydrate
12. Eu 5306
13. Unii-cx28qc6fu0
14. Peflacin
15. Pefloxacin Mesylate Dihydrate [ep]
16. 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Mesylate Dihydrate
17. Mfcd01685696
18. Rb 1589
19. Pefloxacinmesylatedihydrate
20. Hy-b0147b
21. 1589mrb
22. Hms3656n18
23. S4119
24. Akos015896973
25. Ccg-269406
26. Cs-1963
27. Ks-1095
28. 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Compound With Methanesulfonic Acid (1:1) Dihydrate
29. Db-043005
30. Ft-0631178
31. Sw197608-4
32. A836889
33. Pefloxacin Mesylate Dihydrate [ep Impurity]
34. Pefloxacin Methanesulfonate Dihydrate [mi]
35. Pefloxacin Mesilate Dihydrate [ep Monograph]
36. Q27275871
37. Pefloxacin Mesilate Dihydrate, European Pharmacopoeia (ep) Reference Standard
38. 1-ethyl-6-fluoranyl-7-(4-methylpiperazin-1-yl)-4-oxidanylidene-quinoline-3-carboxylic Acid; Methanesulfonic Acid; Dihydrate
39. 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid; Methanesulfonic Acid; Dihydrate
Molecular Weight | 465.5 g/mol |
---|---|
Molecular Formula | C18H28FN3O8S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 3 |
Exact Mass | 465.15811420 g/mol |
Monoisotopic Mass | 465.15811420 g/mol |
Topological Polar Surface Area | 129 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 638 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Cytochrome P-450 CYP1A2 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)
Topoisomerase II Inhibitors
Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
ABOUT THIS PAGE
A Peflacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Peflacin, including repackagers and relabelers. The FDA regulates Peflacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Peflacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Peflacin supplier is an individual or a company that provides Peflacin active pharmaceutical ingredient (API) or Peflacin finished formulations upon request. The Peflacin suppliers may include Peflacin API manufacturers, exporters, distributors and traders.
click here to find a list of Peflacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Peflacin written confirmation (Peflacin WC) is an official document issued by a regulatory agency to a Peflacin manufacturer, verifying that the manufacturing facility of a Peflacin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Peflacin APIs or Peflacin finished pharmaceutical products to another nation, regulatory agencies frequently require a Peflacin WC (written confirmation) as part of the regulatory process.
click here to find a list of Peflacin suppliers with Written Confirmation (WC) on PharmaCompass.
Peflacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Peflacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Peflacin GMP manufacturer or Peflacin GMP API supplier for your needs.
A Peflacin CoA (Certificate of Analysis) is a formal document that attests to Peflacin's compliance with Peflacin specifications and serves as a tool for batch-level quality control.
Peflacin CoA mostly includes findings from lab analyses of a specific batch. For each Peflacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Peflacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Peflacin EP), Peflacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Peflacin USP).
LOOKING FOR A SUPPLIER?